About Eugene Chang
Form D filings for 32 Biosciences in 2024 list Eugene Chang as director.
Eugene Chang first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Eugene Chang in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Eugene Chang works with at each company, as listed on that company's latest Form D.
32 Biosciences, Inc. · Form D, May 31, 2024
JP
Joseph Pierre
Director
BY
Brian Yoor
Director
JC
Jaime Contreras
Director
JA
John Alverdy
Director
PF
Peter Farmakis
Chief Executive Officer and director